| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000044073 |
| Receipt No. | R000050316 |
| Scientific Title | Pharmacokinetics study o of a food containing botanical extract - Randomized crossover study - |
| Date of disclosure of the study information | 2022/01/01 |
| Last modified on | 2022/10/31 (Ver. 4) |
| Basic information | ||
| Public title | Pharmacokinetics study of a food containing botanical extract
- Randomized crossover study - |
|
| Acronym | Pharmacokinetics study of a food containing botanical extract | |
| Scientific Title | Pharmacokinetics study o of a food containing botanical extract
- Randomized crossover study - |
|
| Scientific Title:Acronym | Pharmacokinetics study of a food containing botanical extract | |
| Region |
|
|
| Condition | ||
| Condition | Not applicable | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the pharmacokinetics of functional food |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Maximum observed plasma concentration, Maximum time plasma concentration, Area under the plasma concentration-time curve from time zero to the time of the last measurable drug concentration |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Single ingestion of test food 1 -> Washout(1day) -> Single ingestion of test food 2 | |
| Interventions/Control_2 | Single ingestion of test food 2 -> Washout(1day) -> Single ingestion of test food 1 | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1)Males equal to or more than 20 years and less than 39 years of age
2)Subjects who BMI18.5=> kg/m2 and <30kg/m2 3)Subjects who visit on schedule days 4)Subjects who recognize the object and contents of the study and submit the written informed consent |
|||
| Key exclusion criteria | 1)Subjects who have systolic blood pressure <90 mmHg
2)Subjects who donated 200 mL or more of blood within 4 weeks from the start of the study 3)Subjects who donated 400 mL or more of blood within 12 weeeks from the start of the study 4)Subjects who donated 1200 mL over or more of blood within 12 months from the start of the study 5)Subjects who participated in other clinical studies in the past 4 weeks 6)Subjects who fall under any of the following items a) Subjects who have a history of severe illness and current medical history in the heart, liver, kidney, digestive organs b) Subjects who are under treatment or have a history of cardiovascular disease c) Subjects who develop diabetes d) Subjects who have allergy related to the study foods 7)Subjects who are under treatment 8)Subjects who have history of surgery on gastrointestinal part such as gastrectomy, gastrointestinal suture and intestinal resection 9)Subjects who have allergy related to the foods 10)Subjects who have experienced sickness due to blood collection 11)Subjects who have difficulty drawing blood from the peripheral vein 12)Heavy alcoholic beverager(40g alcohol/day>=) 13)Subjects who quit smoking for less than 6 months or smokers 14)Subjects whose eating habits are extremely irregular 15)Shift worker and night worker 16)Subjects who took medicine before the study 17)Subjects who use oral supplements which may affect this study 18)Subjects who the physician's judgement found difficult to consume the test foods 19)Subjects who are ineligible due to physician's judgement |
|||
| Target sample size | 3 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Medical Corporation Jikokai Shiroishi Internal Medicine Clinic | ||||||
| Division name | General Medicine Clinical Departments : Internal Medicine Respiratory Medicine Allergy | ||||||
| Zip code | 003-0011 | ||||||
| Address | 7-10-30 Chuo-1 jo, Shiroishi-ku, Sapporo, Hokkaido, Japan | ||||||
| TEL | 011-868-2711 | ||||||
| n-abe@medi-ate.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | New drug research center, Inc. | ||||||
| Division name | Clinical Research Dept. | ||||||
| Zip code | 061-1405 | ||||||
| Address | 452-1 Toiso, Eniwa-shi, Hokkaido, Japan | ||||||
| TEL | 0123-34-0412 | ||||||
| Homepage URL | |||||||
| t-ashino@ndrcenter.co.jp | |||||||
| Sponsor | |
| Institute | Maruzen Pharmaceuticals Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Maruzen Pharmaceuticals Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Corporation Jikokai Shiroishi Internal Medicine Clinic Clinical Trial Review Committee |
| Address | 1-2-5 Itoyokado Fukuzumiten-5F Fukuzumi-2 jo, Toyohira-ku, Sapporo, Hokkaido, Japan |
| Tel | 011-836-3531 |
| s-fukui@jikokai.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 16 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050316 |